| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Tramadol hydrochloride |
Is a |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Zolamine |
Is a |
True |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Ethoheptazine |
Is a |
True |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Prodipidine |
Is a |
True |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Phenyramidol (substance) |
Is a |
True |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Levomepromazine hydrochloride |
Is a |
True |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Benzydamine hydrochloride |
Is a |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Non-steroidal anti-inflammatory agent (substance) |
Is a |
True |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Poisoning by co-proxamol |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Intentional non-opiate analgesic overdose (disorder) |
Causative agent (attribute) |
True |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
1 |
| Intentional paracetamol overdose |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Poisoning by nonopioid analgesic |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Accidental paracetamol poisoning |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Intentional paracetamol poisoning |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Acetaminophen poisoning of undetermined intent |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Accidental acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Intentional acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Acetaminophen and dextropropoxyphene poisoning of undetermined intent |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Accidental poisoning by co-proxamol |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Intentional poisoning by co-proxamol |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Poisoning by co-proxamol of undetermined intent |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Non-opioid analgesic adverse reaction |
Causative agent (attribute) |
True |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
1 |
| Adverse reaction caused by paracetamol |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Non-opioid analgesic allergy |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Allergy to paracetamol |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Overdose of nonopioid analgesic |
Causative agent (attribute) |
True |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
1 |
| Paracetamol overdose |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Accidental paracetamol overdose |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Acetaminophen overdose of undetermined intent |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Accidental overdose of non-opiate analgesics |
Causative agent (attribute) |
True |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
1 |
| Overdose of non-opiate analgesics of undetermined intent |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
1 |
| Allergy to acetaminophen and dextropropoxyphene |
Causative agent (attribute) |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Levomepromazine maleate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Non-opioid analgesics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 500mg soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 100 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely paracetamol 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Methionine 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 240 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely paracetamol 120 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 60 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely paracetamol 125 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 120mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 120mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 250mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Methionine 250 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 500mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Co-codamol 8mg/500mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Acetaminophen+dextropropoxyphene hydrochloride 325mg/32.5mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 30 mg and paracetamol 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely diphenhydramine 25 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol+diphenhydramine hydrochloride 120mg/12.5mg s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol+promethazine hydrochloride 120mg/1.5mg/5mL color free s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Analgesics with anti-emetics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Co-codamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 120mg pediatric soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Caffeine 25 mg and paracetamol 450 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 150 mg and sodium salicylate 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Acetaminophen compound preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing dextropropoxyphene and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol+caffeine 500mg/65mg soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Analgesic AND antipyretic product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 80 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 300 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 325 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 80 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Paracetamol 325 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely paracetamol 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesic (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]